肠道微生物组影响检查点阻断。
The intestinal microbiome influences checkpoint blockade.
机构信息
Bloomberg-Kimmel Institute for Immunotherapy, Johns Hopkins University School of Medicine, Balitmore, Maryland, USA.
出版信息
Nat Med. 2018 Mar 6;24(3):254-255. doi: 10.1038/nm.4511.
Abstract
Studies in metastatic melanoma, non-small-cell lung carcinoma and renal cell carcinoma indicate certain bacteria within the gut microbiota enhance clinical responses to checkpoint blockade.
摘要
研究转移性黑色素瘤、非小细胞肺癌和肾细胞癌表明，肠道微生物组中的某些细菌增强了对检查点阻断的临床反应。
相似文献
1
The intestinal microbiome influences checkpoint blockade.肠道微生物组影响检查点阻断。
Nat Med. 2018 Mar 6;24(3):254-255. doi: 10.1038/nm.4511.
2
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.微调癌症免疫疗法：优化肠道微生物组。
Cancer Res. 2016 Aug 15;76(16):4602-7. doi: 10.1158/0008-5472.CAN-16-0448. Epub 2016 Jul 29.
3
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.了解共生功能体：微生物代谢产物如何影响人类健康并塑造免疫系统。
Cell Metab. 2017 Jul 5;26(1):110-130. doi: 10.1016/j.cmet.2017.05.008. Epub 2017 Jun 15.
4
Constipation and the Microbiome: Lumen Versus Mucosa!便秘与微生物群：肠腔与黏膜！
Gastroenterology. 2016 Feb;150(2):300-3. doi: 10.1053/j.gastro.2015.12.023. Epub 2015 Dec 19.
5
Roles of intestinal microbiota in response to cancer immunotherapy.肠道微生物群在癌症免疫治疗中的作用。
Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2235-2240. doi: 10.1007/s10096-018-3374-8. Epub 2018 Sep 12.
6
Gut checkpoint: A rising cancer treatment may get a boost from intestinal bacteria.肠道关卡：一种新兴的癌症治疗方法可能会从肠道细菌中获得助力。
Nat Med. 2018 Mar 6;24(3):251-253. doi: 10.1038/nm0318-251.
7
The Intestinal Eukaryotic and Bacterial Biome of Spotted Hyenas: The Impact of Social Status and Age on Diversity and Composition.斑鬣狗的肠道真核生物和细菌群落：社会地位和年龄对多样性及组成的影响
Front Cell Infect Microbiol. 2017 Jun 16;7:262. doi: 10.3389/fcimb.2017.00262. eCollection 2017.
8
Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.白细胞介素-15通过丁酸缺乏促进肠道微生物群失调，这与结肠炎易感性增加相关。
ISME J. 2017 Jan;11(1):15-30. doi: 10.1038/ismej.2016.114. Epub 2016 Sep 20.
9
Bacterial diversity in the feces of dogs with CPV infection.犬细小病毒感染犬粪便中的细菌多样性。
Microb Pathog. 2018 Aug;121:70-76. doi: 10.1016/j.micpath.2018.04.043. Epub 2018 Apr 27.
10
The Bacterial Microbiome and Virome Milestones of Infant Development.婴儿发育的细菌微生物组和病毒组里程碑。
Trends Microbiol. 2016 Oct;24(10):801-810. doi: 10.1016/j.tim.2016.06.001. Epub 2016 Jun 25.
引用本文的文献
1
Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients.转移性尿路上皮癌患者中抗生素与治疗疗效之间的关联
BMC Med. 2025 Feb 25;23(1):117. doi: 10.1186/s12916-024-03786-1.
2
Gene prediction of immune cells association between gut microbiota and colorectal cancer: a Mendelian randomization study.肠道微生物群与结直肠癌之间免疫细胞关联的基因预测：一项孟德尔随机化研究
Front Immunol. 2025 Jan 31;16:1460936. doi: 10.3389/fimmu.2025.1460936. eCollection 2025.
3
Immune-related adverse events of antibody-based biological medicines in cancer therapy.癌症治疗中基于抗体的生物药物的免疫相关不良反应。
J Cell Mol Med. 2024 Jul;28(13):e18470. doi: 10.1111/jcmm.18470.
4
Understanding and overcoming resistance to immunotherapy in genitourinary cancers.了解并克服泌尿生殖系统癌症的免疫治疗抵抗。
Cancer Biol Ther. 2024 Dec 31;25(1):2342599. doi: 10.1080/15384047.2024.2342599. Epub 2024 Apr 17.
5
Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy.肠道微生物群：癌症免疫治疗进展背后的驱动力
Cancers (Basel). 2022 Sep 30;14(19):4796. doi: 10.3390/cancers14194796.
6
The role of gut microbiome in immune modulation in metastatic renal cell carcinoma.肠道微生物群在转移性肾细胞癌免疫调节中的作用。
Ther Adv Med Oncol. 2022 Sep 8;14:17588359221122714. doi: 10.1177/17588359221122714. eCollection 2022.
7
Interaction between microbiota and immunity and its implication in colorectal cancer.肠道微生物群与免疫相互作用及其在结直肠癌中的意义。
Front Immunol. 2022 Jul 29;13:963819. doi: 10.3389/fimmu.2022.963819. eCollection 2022.
8
Microenvironmental Metabolites in the Intestine: Messengers between Health and Disease.肠道中的微环境代谢产物：健康与疾病之间的信使
Metabolites. 2022 Jan 7;12(1):46. doi: 10.3390/metabo12010046.
9
Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota.肠道微生物群改变对基于PD-1的非小细胞肺癌免疫治疗的反应。
Oncol Ther. 2021 Dec;9(2):647-657. doi: 10.1007/s40487-021-00171-3. Epub 2021 Oct 18.
10
Expression, prognostic significance and therapeutic implications of PD-L1 in gliomas.PD-L1 在脑胶质瘤中的表达、预后意义及治疗意义。
Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12767. doi: 10.1111/nan.12767. Epub 2021 Oct 20.
本文引用的文献
1
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.共生微生物群与转移性黑色素瘤患者的抗PD-1疗效相关。
Science. 2018 Jan 5;359(6371):104-108. doi: 10.1126/science.aao3290.
2
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.肠道微生物组影响基于 PD-1 的免疫疗法对上皮性肿瘤的疗效。
Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.
3
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.肠道微生物群调节黑色素瘤患者对抗PD-1免疫疗法的反应。
Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.
4
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.基线肠道微生物群可预测接受伊匹单抗治疗的转移性黑色素瘤患者的临床应答和结肠炎。
Ann Oncol. 2017 Jun 1;28(6):1368-1379. doi: 10.1093/annonc/mdx108.
5
Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma.尼伏鲁单抗单药治疗的安全性概况：晚期黑色素瘤患者的汇总分析。
J Clin Oncol. 2017 Mar;35(7):785-792. doi: 10.1200/JCO.2015.66.1389. Epub 2016 Nov 14.
6
The Human Intestinal Microbiome in Health and Disease.健康与疾病中的人类肠道微生物群
N Engl J Med. 2016 Dec 15;375(24):2369-2379. doi: 10.1056/NEJMra1600266.
7
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.通过CTLA-4阻断进行的抗癌免疫疗法依赖于肠道微生物群。
Science. 2015 Nov 27;350(6264):1079-84. doi: 10.1126/science.aad1329. Epub 2015 Nov 5.
8
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.共生双歧杆菌可促进抗肿瘤免疫并增强抗程序性死亡受体配体1（PD-L1）的疗效。
Science. 2015 Nov 27;350(6264):1084-9. doi: 10.1126/science.aac4255. Epub 2015 Nov 5.
9
Immune checkpoint blockade: a common denominator approach to cancer therapy.免疫检查点阻断：癌症治疗的一种通用方法。
Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6.
10
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.肠道微生物群调节环磷酰胺的抗癌免疫作用。
Science. 2013 Nov 22;342(6161):971-6. doi: 10.1126/science.1240537.
Zotero 插件